Hallucinations: Difference between revisions
No edit summary |
ClaireLewis (talk | contribs) No edit summary |
||
| Line 7: | Line 7: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
===Organic causes=== | |||
*[[Delirium]] | |||
*[[Intracranial mass]] to occipital or temporal lobes | |||
*[[Encephalitis]], [[limbic encephalitis]], [[anti-NMDA receptor encephalitis]] | |||
*[[Migraine]] | |||
*[[Seizure]] | |||
*[[Hypocalcemia]]/[[Hypercalcemia]] | |||
*[[Rift valley fever]] | |||
*[[Rabies]] | |||
*[[Syphilis]] | |||
*[[Vitamin B7 deficiency]] | |||
*[[Pellagra]] | |||
*[[Dementia]] | |||
*[[Parkinson's Disease]] | |||
{{Hallucinogen types}} | {{Hallucinogen types}} | ||
| Line 13: | Line 29: | ||
{{Dissociative drugs types}} | {{Dissociative drugs types}} | ||
===Other | ====Other Toxicologic Causes==== | ||
*[[Alcohol Withdrawal]] | *[[Alcohol Withdrawal]] | ||
*[[Anticholinergic Toxicity]] | *[[Anticholinergic Toxicity]] | ||
*[[Tricyclic (TCA) Toxicity]] | *[[Tricyclic (TCA) Toxicity]] | ||
*[[ | *[[Synthetic cannabinoids]] | ||
*[[ | *[[Inhalant abuse]] | ||
*[[ | *[[Nitrogen narcosis]] | ||
*[[GHB withdrawal]] | |||
*[[Hydrocarbon toxicity]] | |||
*[[Heavy metal toxicity]] | |||
*Multiple medications: [[montelukast]], [[doxapram]], [[hyoscyamine]], [[tizanidine]], [[peramivir]], [[amantadine]], [[rimantadine]], [[bromocriptine]], [[methylergonovine]], [[benztropine]], [[doxepin]], [[voriconazole]], [[aciclovir]], [[valacyclovir]], [[ganciclovir]], [[cimetidine]], [[penicillin G procaine]], [[clarithromycin]], [[metoclopramide]] | |||
*[[Inhalant abuse]] | |||
===Psychiatric Causes <ref>Visual Hallucinations: Differential Diagnosis and Treatment. PMID PMC2660156</ref>=== | ===Psychiatric Causes <ref>Visual Hallucinations: Differential Diagnosis and Treatment. PMID PMC2660156</ref>=== | ||
*[[Schizophrenia]], [[schizoaffective disorder]], [[schizophreniform disorder]] | |||
*[[ | *[[Depression]] with psychotic features | ||
*[[Bipolar disorder]] | |||
*[[ | |||
*[[ | |||
*Charles Bonnet Syndrome (in the visually impaired) | *Charles Bonnet Syndrome (in the visually impaired) | ||
==Evaluation== | ==Evaluation== | ||
*Workup should be targeted toward specific diagnosis. | *Workup should be targeted toward specific diagnosis. | ||
*In non-auditory hallucinations, assume organic pathology until proven otherwise. | *In non-auditory hallucinations, assume organic pathology until proven otherwise. | ||
*New diagnosis of psychiatric disease as cause of hallucinations should generally not be made in ED without first ruling out organic pathology | |||
*If concern for suicidal or unknown toxic ingestion: | *If concern for suicidal or unknown toxic ingestion: | ||
**Acetaminophen level | **Acetaminophen level | ||
| Line 40: | Line 60: | ||
==Management== | ==Management== | ||
*Treat the underlying pathology. | *Treat the underlying pathology. | ||
*If hallucinations distressing, can trial dose of PO [[antipsychotic]] | |||
*In the case of alcohol withdrawal hallucinosis, no standard therapy has been established,<ref> Neuroleptic treatment of alcohol hallucinosis: case series. PMID 18030655</ref> although treatment with neuroleptics (e.g. Haldol) has shown some benefit. <ref>Alcohol-induced hallucinosis. Clinical aspects, pathophysiology and therapy. PMID 9064548</ref> Also continue to treat the [[Alcohol Withdrawl |alcohol withdrawal]]. | *In the case of alcohol withdrawal hallucinosis, no standard therapy has been established,<ref> Neuroleptic treatment of alcohol hallucinosis: case series. PMID 18030655</ref> although treatment with neuroleptics (e.g. Haldol) has shown some benefit. <ref>Alcohol-induced hallucinosis. Clinical aspects, pathophysiology and therapy. PMID 9064548</ref> Also continue to treat the [[Alcohol Withdrawl |alcohol withdrawal]]. | ||
| Line 46: | Line 67: | ||
*[[Alcohol withdrawal]] | *[[Alcohol withdrawal]] | ||
*[[Hallucinogens]] | *[[Hallucinogens]] | ||
*[[Psychosis]] | |||
==References== | ==References== | ||
Revision as of 03:01, 3 October 2019
Background
- The perception of auditory, visual, tactile, or gustatory sensations without an actual stimulus
- Etiology may be from underlying psychiatric disorder or organic cause.
Clinical Features
Differential Diagnosis
Organic causes
- Delirium
- Intracranial mass to occipital or temporal lobes
- Encephalitis, limbic encephalitis, anti-NMDA receptor encephalitis
- Migraine
- Seizure
- Hypocalcemia/Hypercalcemia
Hallucinations
Serotonin-Like Agents
- Lysergic acid diethylamide (LSD)
- Psilocybin ("magic mushrooms")
- N,N-Dimethyltryptamine (DMT)
- 5-methoxy- dimethyltryptamine (5-MeO-DMT)
- 25C-NBOMe
Enactogens
- Designer amphetamines
- Bath salts
- Ecstasy (MDMA)
- Mescaline (peyote)
- Synthetic cannabinoids
Dissociative Agents
- Phencyclidine (PCP)
- Ketamine
- Dextromethorphan
- Nitrous oxide
Plant-based Hallucinogenics
- Marijuana
- Salvia
- Absinthe
- Isoxazole Mushrooms
- Hawaiian baby woodrose (Argyreia nervosa)
- Hawaiian woodrose (Merremia tuberosa)
- Morning glory (Ipomoea violacea)
- Olili- uqui (Rivea corymbosa)
Organic causes
- Delirium
- Intracranial mass to occipital or temporal lobes
- Encephalitis, limbic encephalitis, anti-NMDA receptor encephalitis
- Migraine
- Seizure
- Hypocalcemia/Hypercalcemia
- Rift valley fever
- Rabies
- Syphilis
- Vitamin B7 deficiency
- Pellagra
- Dementia
Other Toxicologic Causes
- Alcohol withdrawal
- Anticholinergic Toxicity
- Tricyclic (TCA) Toxicity
- Synthetic cannabinoids
- Inhalant abuse
- Nitrogen narcosis
- GHB withdrawal
- Hydrocarbon toxicity
- Heavy metal toxicity
- Multiple medications: montelukast, doxapram, hyoscyamine, tizanidine, peramivir, amantadine, rimantadine, bromocriptine, methylergonovine, benztropine, doxepin, voriconazole, acyclovir, valacyclovir, ganciclovir, cimetidine, penicillin G Procaine, clarithromycin, metoclopramide
- Inhalant abuse
Psychiatric Causes [1]
- Schizophrenia, schizoaffective disorder, schizophreniform disorder
- Depression with psychotic features
- Bipolar disorder
- Charles Bonnet Syndrome (in the visually impaired)
Sedative/hypnotic toxicity
- Absinthe
- Barbiturates
- Benzodiazepines
- Chloral hydrate
- Gamma hydroxybutyrate (GHB)
- Baclofen toxicity
- Opioids
- Toxic alcohols
- Xylazine toxicity
Dissociative drugs
Other Toxicologic Causes
- Alcohol Withdrawal
- Anticholinergic Toxicity
- Tricyclic (TCA) Toxicity
- Synthetic cannabinoids
- Inhalant abuse
- Nitrogen narcosis
- GHB withdrawal
- Hydrocarbon toxicity
- Heavy metal toxicity
- Multiple medications: montelukast, doxapram, hyoscyamine, tizanidine, peramivir, amantadine, rimantadine, bromocriptine, methylergonovine, benztropine, doxepin, voriconazole, aciclovir, valacyclovir, ganciclovir, cimetidine, penicillin G procaine, clarithromycin, metoclopramide
- Inhalant abuse
Psychiatric Causes [2]
- Schizophrenia, schizoaffective disorder, schizophreniform disorder
- Depression with psychotic features
- Bipolar disorder
- Charles Bonnet Syndrome (in the visually impaired)
Evaluation
- Workup should be targeted toward specific diagnosis.
- In non-auditory hallucinations, assume organic pathology until proven otherwise.
- New diagnosis of psychiatric disease as cause of hallucinations should generally not be made in ED without first ruling out organic pathology
- If concern for suicidal or unknown toxic ingestion:
- Acetaminophen level
- Salicylate level
- ECG
Management
- Treat the underlying pathology.
- If hallucinations distressing, can trial dose of PO antipsychotic
- In the case of alcohol withdrawal hallucinosis, no standard therapy has been established,[3] although treatment with neuroleptics (e.g. Haldol) has shown some benefit. [4] Also continue to treat the alcohol withdrawal.
See Also
References
- ↑ Visual Hallucinations: Differential Diagnosis and Treatment. PMID PMC2660156
- ↑ Visual Hallucinations: Differential Diagnosis and Treatment. PMID PMC2660156
- ↑ Neuroleptic treatment of alcohol hallucinosis: case series. PMID 18030655
- ↑ Alcohol-induced hallucinosis. Clinical aspects, pathophysiology and therapy. PMID 9064548
